QNCX Logo

Quince Therapeutics, Inc. (QNCX) 

NASDAQ
Market Cap
$30.32M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
134 of 809
Rank in Industry
89 of 445

Largest Insider Buys in Sector

QNCX Stock Price History Chart

QNCX Stock Performance

About Quince Therapeutics, Inc.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Insider Activity of Quince Therapeutics, Inc.

Over the last 12 months, insiders at Quince Therapeutics, Inc. have bought $909,017 and sold $0 worth of Quince Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Quince Therapeutics, Inc. have bought $1M and sold $1,834 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Lamond David (director) — $601,547. Thye Dirk (Chief Executive Officer) — $210,080. Hannah Brendan (Chief Business Officer) — $87,550.

The last purchase of 22,627 shares for transaction amount of $23,532 was made by Lamond David (director) on 2023‑12‑14.

List of Insider Buy and Sell Transactions, Quince Therapeutics, Inc.

2023-12-14PurchaseLamond Daviddirector
22,627
0.0528%
$1.04$23,532+4.82%
2023-12-13PurchaseLamond Daviddirector
22,627
0.0528%
$1.00$22,627+9.04%
2023-12-12PurchaseLamond Daviddirector
22,627
0.0544%
$1.02$23,074+9.00%
2023-12-07PurchaseLamond Daviddirector
19,123
0.0446%
$1.01$19,314+7.92%
2023-12-06PurchaseLamond Daviddirector
19,123
0.0455%
$1.02$19,505+9.00%
2023-12-05PurchaseLamond Daviddirector
19,123
0.0466%
$1.01$19,314+11.00%
2023-12-01PurchaseLamond Daviddirector
14,378
0.033%
$0.94$13,515+13.78%
2023-11-30PurchaseLamond Daviddirector
14,378
0.035%
$0.90$12,940+25.29%
2023-11-29PurchaseLamond Daviddirector
14,378
0.035%
$0.98$14,090+14.35%
2023-08-31PurchaseLamond Daviddirector
41,026
0.1136%
$1.32$54,154-19.08%
2023-08-30PurchaseLamond Daviddirector
41,026
0.1145%
$1.31$53,744-17.83%
2023-08-17PurchaseLamond Daviddirector
24,766
0.0684%
$1.29$31,948-15.75%
2023-08-16PurchaseLamond Daviddirector
117,348
0.323%
$1.29$151,379-17.05%
2023-08-15PurchaseLamond Daviddirector
107,886
0.3087%
$1.32$142,410-15.35%
2023-08-10PurchaseThye DirkChief Executive Officer
88,000
0.2461%
$1.26$110,880-12.10%
2023-08-08PurchaseThye DirkChief Executive Officer
80,000
0.2238%
$1.24$99,200-10.66%
2023-08-08PurchaseHannah BrendanChief Business Officer
71,762
0.1975%
$1.22$87,550-10.66%
2023-08-08PurchaseMcLoughlin Margaretdirector
8,000
0.0222%
$1.23$9,840-10.66%
2023-03-06SaleMonohon TedChief Accounting Officer & VP
1,871
0.0051%
$0.98$1,834+27.25%
2020-06-12PurchaseEPIQ Capital Group, LLC
2,440
0.0081%
$44.06$107,506-4.71%

Insider Historical Profitability

23.94%
Lamond Daviddirector
2347545
5.4761%
$0.70140
Thye DirkChief Executive Officer
448911
1.0472%
$0.7020
Hannah BrendanChief Business Officer
201555
0.4702%
$0.7010
McLoughlin Margaretdirector
8000
0.0187%
$0.7010
EPIQ Capital Group, LLC
2860967
6.6738%
$0.70100+23.94%
Monohon TedChief Accounting Officer & VP
27440
0.064%
$0.7001

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Tang Capital Management, LLC$3.12M6.822.95M-8.46%-$288,688.870.01
The Vanguard Group$1.2M2.621.13M+16.44%+$169,312.77<0.0001
EPIQ Capital Group$896,519.001.96845,773-2.8%-$25,821.590.36
Renaissance Technologies$551,000.001.2520,100+13.39%+$65,069.06<0.01
BlackRock$352,010.000.77332,086-1.05%-$3,729.07<0.0001
Geode Capital Management$282,989.000.62266,896+1.97%+$5,469.01<0.0001
Alphabet$200,469.000.44189,1220%+$00.01
Bank of America$180,095.000.39169,901-0.08%-$137.80<0.0001
Bridgeway Capital Management$146,805.000.32138,4950%+$0<0.01
Two Sigma Advisers LP$102,926.000.2397,100-11.73%-$13,674.00<0.0001
Susquehanna International Group$102,589.000.2296,782-3.29%-$3,493.76<0.0001
Scharf Investments$96,525.000.2191,0610%+$0<0.01
Mariner Llc$78,518.000.1774,0740%+$0<0.0001
State Street$60,008.000.1356,6110%+$0<0.0001
Millennium Management LLC$56,900.000.1253,679-9.7%-$6,114.11<0.0001
Intellectus Partners$56,967.000.1253,742+0.4%+$227.900.02
Northern Trust$36,124.000.0834,079-22.3%-$10,365.82<0.0001
Citadel Advisors LLC$28,043.000.0626,456New+$28,043.00<0.0001
IEQ Capital$23,874.000.0522,523New+$23,874.00<0.0001
Kestra Advisory Services LLC$13,724.000.0312,947New+$13,724.00<0.0001
Watch Point Trust Co$11,794.000.0311,1260%+$0<0.01
Charles Schwab$11,674.000.0311,0130%+$0<0.0001
Orion Portfolio Solutions Llc$10,744.000.0210,1360%+$0<0.0001
Morgan Stanley$8,904.000.028,400-7.56%-$728.22<0.0001
Tower Research Capital$7,715.000.027,278+7.84%+$560.76<0.0001
Citigroup$5,475.000.015,1650%+$0<0.0001
Simplex Trading Llc$4,000.000.014,707+606.76%+$3,434.03<0.0001
Group One Trading$1,704.00<0.011,608New+$1,704.00<0.0001
Fidelity Investments$1,590.00<0.011,500New+$1,590.00<0.0001
UBS$536.00<0.015050%+$0<0.0001
Jdm Financial Group Llc$360.00<0.013400%+$0<0.0001
Parallel Advisors, LLC$330.00<0.01311-86.91%-$2,191.16<0.0001
RhumbLine Advisers$417.00<0.013940%+$0<0.0001
Royal Bank of Canada$0<0.01221+68.7%+$0<0.0001
JPMorgan Chase$497.00<0.014690%+$0<0.0001
Wells Fargo$284.00<0.01268-78.8%-$1,055.46<0.0001
Advisor Group Holdings Inc$293.00<0.012770%+$0<0.0001
Westside Investment Management Inc$80.00<0.01750%+$0<0.0001
Financial Avengers Inc$109.00<0.011000%+$0<0.0001
Barclays$0<0.011000%+$0<0.0001